Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
08-Jul-2026 | 420 | 430.7 | 401.3 | 403.25 | 7,839 | 13,08,34,473.3 | 1,88,504 |
09-Jul-2026 | 405 | 410.95 | 403.65 | 407.05 | 7,190 | 15,33,19,684.4 | 2,53,299 |
10-Jul-2026 | 409 | 409 | 398.25 | 402.7 | 7,793 | 15,66,88,607.15 | 2,26,248 |
13-Jul-2026 | 402 | 411.3 | 397.85 | 399.8 | 18,610 | 22,72,79,198.05 | 4,15,763 |
14-Jul-2026 | 396.05 | 410.5 | 396.05 | 399.25 | 8,480 | 16,60,76,026.9 | 2,47,660 |
15-Jul-2026 | 401.1 | 402.6 | 390.1 | 392.45 | 3,987 | 5,09,21,774 | 85,597 |
16-Jul-2026 | 391.65 | 393.4 | 384.05 | 387.1 | 3,788 | 5,40,03,231.4 | 73,925 |
17-Jul-2026 | 390.2 | 391.7 | 380.8 | 387.75 | 3,625 | 4,61,78,226.95 | 61,256 |
20-Jul-2026 | 389.4 | 393.35 | 383.45 | 384.45 | 1,902 | 2,35,01,888.55 | 32,096 |
21-Jul-2026 | 384.5 | 390.7 | 383.05 | 388.2 | 2,358 | 2,49,59,194.85 | 30,903 |
22-Jul-2026 | 387 | 392.95 | 378 | 386.55 | 3,782 | 5,35,75,280.35 | 86,833 |
23-Jul-2026 | 386.95 | 388.4 | 379.8 | 384.65 | 3,523 | 6,12,95,930.2 | 1,05,269 |
24-Jul-2026 | 385.5 | 386 | 378.3 | 381.1 | 2,045 | 1,84,45,576 | 25,496 |
27-Jul-2026 | 385.95 | 396.35 | 385 | 391.9 | 3,907 | 3,86,50,265.3 | 46,938 |
28-Jul-2026 | 391.9 | 391.9 | 379.3 | 380.75 | 3,170 | 3,93,22,846.2 | 66,430 |
29-Jul-2026 | 382.3 | 398.75 | 380.35 | 396.65 | 6,825 | 8,95,77,684.3 | 1,07,635 |
30-Jul-2026 | 395.25 | 399.95 | 372.6 | 374.65 | 10,166 | 12,91,05,675.05 | 2,01,035 |
31-Jul-2026 | 377.95 | 384.8 | 365.4 | 373.9 | 6,205 | 9,00,36,973.25 | 1,21,070 |
03-Aug-2026 | 375.75 | 376.6 | 361.2 | 363.55 | 7,068 | 10,96,90,618.75 | 1,72,137 |
04-Aug-2026 | 365.5 | 369.8 | 361.7 | 363.5 | 5,206 | 8,62,89,971.5 | 1,15,623 |
05-Aug-2026 | 367 | 368.9 | 360.5 | 364.55 | 3,273 | 5,15,52,442.2 | 77,821 |
06-Aug-2026 | 366 | 368.2 | 355.5 | 357.2 | 4,462 | 6,47,70,760.85 | 1,21,528 |
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
